
adMare BioInnovations Launches Ocythera: A New Canadian Life Sciences Company Advancing Therapies for Rare Bone Diseases
adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to…
The BIOQuébec team is pleased to invite you to discover the …
A rich legacy for your association Dear members of the ecosystem, The past year has been one of action and…
As we approach the end of 2025, I would like to look back on the last few months, which have…
We are delighted to present the November 2025 edition of our newsletter. This new issue highlights …
We are pleased to bring you the October 2025 edition of our newsletter. In this new issue, we invite you…
August was another busy month for BIOQuébec, with 50 events, meetings, and…
As the first half of the year draws to a close, the summer months have been busy. BIOQuébec’s pace of…
As the first half of the year draws to a close, the pace of BIOQuébec’s activities remains steady and intense.…
The release of the Quebec budget in March confirmed a number of positive trends for our industry, but also revealed…

adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to…
We use cookies to improve your browsing experience and analyze our traffic. By clicking "Accept", you consent to our use of cookies.
Privacy Policy
